Healthcare stock which is one of the largest private multi-specialty tertiary care providers in focus following plans of building a new 500+ bedded hospital with an investment of Rs. 1,200 Crores
Price Action
With a market capitalization of Rs. 31,582 Crores, the shares of Global Health Limited Closed at Rs. 1,176.05 per equity share, down 1.28 percent from the previous day’s close price of Rs. 1,191.25.
What Happened
In regard to its earlier intimation of Global Health Limited participating in the e-auction tender of land issued by the Mumbai Housing and Area Development Authority (MHADA) measuring 8859.24 sq. meters, it has been declared as the successful bidder for the land for a consideration of Rs. 125.11 Crores.
Global Health Limited acquired the said land for the purpose of constructing a new 500+ bedded Hospital with an estimated project capex of Rs. 1,200 crores, thereby expanding its operations and efficiency.
Also read
About the Company
Global Health Limited (Medanta) is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services, and others.
Global Health Limited has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology
Financials and Ratios
Its Revenue from operations grew by 21.56 percent from Rs. 2,694 Crores in FY23 to Rs. 3,275 Crores in FY24, accompanied by profits of Rs. 326 Crores to Rs. 478 Crores.
In terms of Return ratios, it has reported a return on equity (ROE) of 17.9 percent, and a return on capital employed (ROCE) of 17.6 percent. It has reported a debt-to-equity ratio of 0.28.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
